Spinocerebellar ataxia type 1 (SCA1) is a neurodegenerative disease caused by the expansion of a translated CAG repeat encoding glutamine in the ataxin-1 (Atx-1) protein. Interestingly, while overexpression of mutant Atx-1 with an expanded polyQ tract causes neurodegeneration in mice and flies, even human Atx-1 with a nonpathogenic repeat of (CAG)14CAT-CAG-CAT(CAG)15, such as hAtx-1[30Q], causes neuronal degeneration if expressed at sufficiently high levels in either mice or Drosophila. To understand the physiological consequences of overexpression of Atx-1 in flies, the yeast two hybrid system was employed where wild-type ataxin-1 under UAS was driven pan-neuronally in nervous tissue of Drosophila melanogaster using the elav-GAL4 driver (elav-GAL4/UAS-Atx-1). Parallel controls were UAS-ATX-1/+ and elav-GAL4/+. The lifespan of flies overexpressing Atx-1 was significantly reduced compared to controls. While daily locomotor activity rhythms were not markedly affected, the negative geotaxis response was significantly impacted in flies overexpressing Atx-1. The expression of armadillo which is required for both for cell–cell adhesion and for regulating gene expression during development was markedly reduced. Moreover, Drosophila Nemo (nmo) a member of a conserved family of protein kinases that have roles in diverse signaling processes during development was also affected. Taken together, our results point to a specific level of ataxin necessary for proper development and enhanced levels can have physiologically detrimental effects.
No takes yet. Share an insight, caveat, or question.
Davis et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: